India
New Omicron Vaccine to Be Ready By March
Pfizer and BioNTech launch trial of Omicron-targeted COVID vaccine. Watch our video for all the details.
Cinema
Hero cinema
Grid
Fast scan
Newspaper
Front page
Magazine
Feature flow
Showcase
Big lead
Portal
Surprise stack
More layouts
Split Spotlight Layout
Editorial Grid Layout
Trending Row Layout
Spotlight Duo Layout
Rolling Rail Layout
Orbit Roll Layout
Jumping Cards Layout
Masonry Cards Layout
Poster Wall Layout
Headline Stack Layout
Timeline Layout
Ribbon Rail Layout
Billboard Grid Layout
Compact List Layout
Social Feed Layout
Cinema Tiles Layout
Metro Board Layout
Prism Grid Layout
Capsule Rail Layout
Archive Cards Layout
Split Column Layout
Diagonal Stack Layout
Lighthouse Layout
Scoreboard Layout
Notebook Layout
Pinboard Layout
Gallery Strip Layout
Waveform Layout
Compass Grid Layout
Studio Wall Layout
Briefing Layout
Carousel Cards Layout
Tablet Grid Layout
Ladder Layout
Cover Story Layout
Vertical Reels Layout
Signal Board Layout
Atlas Layout
Shelf Layout
Bulletin Layout
Mosaic Plus Layout
Radar Layout
Parchment Layout
Glass Grid Layout
Spotlight Strip Layout
Index Cards Layout
Runway Grid Layout
Information Beyond Words
World
US Nurse Faints After Taking Vaccine
A nurse at a Chattanooga hospital in Tennessee, United States fainted at a press conference after receiving the Pfizer-B...
World
UK Issues Allergy Warning For COVID Vaccine
UK’s regulatory MHRA has said that anyone who has a history of anaphylaxis should not get the Pfizer-BioNTech COVID-19 v...
World
UK Approves Widespread Use of Pfizer Vaccine
Britain has become the first country to approve Pfizer-BioNTech's Covid-19 vaccine for general use from next week.
World
Pfizer’s COVID-19 Vaccine 95 Percentage Effective
Pharmaceutical giant Pfizer and German drugmaker BioNTech on Wednesday said their COVID-19 vaccine has been found 95% ef...
World
Pfizer COVID-19 Vaccine 90 percentage Effective
United States pharmaceutical giant Pfizer and German biotech firm BioNTech have said their COVID-19 vaccine is over 90%...
Our Supporters
